Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1977 May;59(5):761–769. doi: 10.1172/JCI108697

Defective recognitive immunity in family aggregates of colon carcinoma.

N T Berlinger, C Lopez, M Lipkin, J E Vogel, R A Good
PMCID: PMC372283  PMID: 140182

Abstract

Cancer-free individuals from family agregates of seemingly hereditary colon carcinoma were studied to determine the nature of their cell-mediated immune capacities in miexed leukocyte culture. Members of families who demonstrated no evidence of a precancerous condition such as polyposis coli did demonstrate substantial cellular immunopathology. Of these, 44% showed a decreased responsiveness of their peripheral mononuclear cells to allogeneic stimuli, and in a number of these individuals this deficiency clearly manifested itself as an inappropriate suppression of potentially normal lymphocyte blastogenic capacities by an adherent population of mononuclear leukocytes. This in vitro defect of recognitive immunity appears to be the same type of defect that has already been described for individuals with established maligancies. The pattern of phenotypic expression of this immunopathology within these families is not inconsistent with an hereditary disorder. Individuals from families with a known hereditary somatic precancerous condition usually did not demonstrate this immunopathology. It is appropriate to speculate that the defect of recognitive immunity in the former families could be contributory to the genesis of the colon carcinoma.

Full text

PDF
761

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bach F. H. Normal histocompatibility antigens as a model for tumors. Am J Clin Pathol. 1974 Aug;62(2):173–183. doi: 10.1093/ajcp/62.2.173. [DOI] [PubMed] [Google Scholar]
  2. Bentwich Z., Douglas S. D., Siegal F. P., Kunkel H. G. Human lymphocyte-sheep erythrocyte rosette formation: some characteristics of the interaction. Clin Immunol Immunopathol. 1973 Jul;1(4):511–522. doi: 10.1016/0090-1229(73)90007-x. [DOI] [PubMed] [Google Scholar]
  3. Berlinger N. T., Good R. A. Concomitant immunopathology with squamous cell carcinomas of the head and neck regions. Trans Sect Otolaryngol Am Acad Ophthalmol Otolaryngol. 1976 Sep-Oct;82(5):588–594. [PubMed] [Google Scholar]
  4. Berlinger N. T., Lopez C., Good R. A. Facilitation or attenuation of mixed leukocyte culture responsiveness by adherent cells. Nature. 1976 Mar 11;260(5547):145–146. doi: 10.1038/260145a0. [DOI] [PubMed] [Google Scholar]
  5. Calderon J., Unanue E. R. Two biological activities regulating cell proliferation found in cultures of peritoneal exudate cells. Nature. 1975 Jan 31;253(5490):359–361. doi: 10.1038/253359a0. [DOI] [PubMed] [Google Scholar]
  6. Cleaver J. E. Xeroderma pigmentosum: a human disease in which an initial stage of DNA repair is defective. Proc Natl Acad Sci U S A. 1969 Jun;63(2):428–435. doi: 10.1073/pnas.63.2.428. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Creagan E. T., Fraumeni J. F., Jr Familial gastric cancer and immunologic abnormalities. Cancer. 1973 Dec;32(6):1325–1331. doi: 10.1002/1097-0142(197312)32:6<1325::aid-cncr2820320606>3.0.co;2-9. [DOI] [PubMed] [Google Scholar]
  8. Dupont B., Good R. A. Lymphocyte transformation in vitro in patients with immunodeficiency diseases: use in diagnosis, histocompatibility testing and monitoring treatment. Birth Defects Orig Artic Ser. 1975;11(1):477–485. [PubMed] [Google Scholar]
  9. Fraumeni J. F., Jr, Vogel C. L., DeVita V. T. Familial chronic lymphocytic leukemia. Ann Intern Med. 1969 Aug;71(2):279–284. doi: 10.7326/0003-4819-71-2-279. [DOI] [PubMed] [Google Scholar]
  10. Fraumeni J. F., Wertelecki W., Blattner W. A., Jensen R. D., Leventhal B. G. Varied manifestations of a familial lymphoproliferative disorder. Am J Med. 1975 Jul;59(1):145–151. doi: 10.1016/0002-9343(75)90333-2. [DOI] [PubMed] [Google Scholar]
  11. Han T., Takita H. Impaired lymphocyte response to allogeneic cultured lymphoid cells in patients with lung cancer. N Engl J Med. 1972 Mar 16;286(11):605–606. doi: 10.1056/nejm197203162861113. [DOI] [PubMed] [Google Scholar]
  12. Kersey J. H., Spector B. D., Good R. A. Primary immunodeficiency diseases and cancer: the immunodeficiency-cancer registry. Int J Cancer. 1973 Sep 15;12(2):333–347. doi: 10.1002/ijc.2910120204. [DOI] [PubMed] [Google Scholar]
  13. Knudson A. G., Jr Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci U S A. 1971 Apr;68(4):820–823. doi: 10.1073/pnas.68.4.820. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Ly I. A., Mishell R. I. Separation of mouse spleen cells by passage through columns of sephadex G-10. J Immunol Methods. 1974 Aug;5(3):239–247. doi: 10.1016/0022-1759(74)90108-2. [DOI] [PubMed] [Google Scholar]
  15. Lynch H. T. Familial cancer prevalence spanning eight years. Family N. Arch Intern Med. 1974 Nov;134(5):931–938. [PubMed] [Google Scholar]
  16. Lynch H. T., Krush A. J. Cancer family "G" revisited: 1895-1970. Cancer. 1971 Jun;27(6):1505–1511. doi: 10.1002/1097-0142(197106)27:6<1505::aid-cncr2820270635>3.0.co;2-l. [DOI] [PubMed] [Google Scholar]
  17. Lynch H. T., Krush A. J. Heredity and adenocarcinoma of the colon. Gastroenterology. 1967 Oct;53(4):517–527. [PubMed] [Google Scholar]
  18. MCKUSICK V. A. Genetic factors in intestinal polyposis. JAMA. 1962 Oct 20;182:271–277. doi: 10.1001/jama.1962.03050420047012. [DOI] [PubMed] [Google Scholar]
  19. Nathan C. F., Hill V. M., Terry W. D. Isolation of a subpopulation of adherent peritoneal cells with anti-tumour activity. Nature. 1976 Mar 11;260(5547):146–148. doi: 10.1038/260146a0. [DOI] [PubMed] [Google Scholar]
  20. Nathan C. F., Terry W. D. Differential stimulation of murine lymphoma growth in vitro by normal and BCG-activated macrophages. J Exp Med. 1975 Oct 1;142(4):887–902. doi: 10.1084/jem.142.4.887. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Peltokallio P., Peltokallio V. Relationship of familial factors to carcinoma of the colon. Dis Colon Rectum. 1966 Sep-Oct;9(5):367–370. doi: 10.1007/BF02617105. [DOI] [PubMed] [Google Scholar]
  22. Potolsky A. I., Heath C. W., Jr, Buckley C. E., 3rd, Rowlands D. T., Jr Lymphoreticular malignancies and immunologic abnormalities in a sibship. Am J Med. 1971 Jan;50(1):42–48. doi: 10.1016/0002-9343(71)90203-8. [DOI] [PubMed] [Google Scholar]
  23. Rauh J. L., Soukup S. W. Bloom's syndrome. Am J Dis Child. 1968 Oct;116(4):409–413. doi: 10.1001/archpedi.1968.02100020413012. [DOI] [PubMed] [Google Scholar]
  24. SAVAGE D. A family history of uterine and gastro-intestinal cancer. Br Med J. 1956 Aug 11;2(4988):341–343. doi: 10.1136/bmj.2.4988.341. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Swift M. Fanconi's anaemia in the genetics of neoplasia. Nature. 1971 Apr 9;230(5293):370–373. doi: 10.1038/230370a0. [DOI] [PubMed] [Google Scholar]
  26. TURCOT J., DESPRES J. P., ST PIERRE F. Malignant tumors of the central nervous system associated with familial polyposis of the colon: report of two cases. Dis Colon Rectum. 1959 Sep-Oct;2:465–468. doi: 10.1007/BF02616938. [DOI] [PubMed] [Google Scholar]
  27. Taylor W. B., Anderson D. E., Howell J. B., Thurston C. S. The nevoid basal cell carcinoma syndrome. Autopsy findings. Arch Dermatol. 1968 Dec;98(6):612–614. [PubMed] [Google Scholar]
  28. Thorsby E., Helgesen A., Rankin B., Möller E., Kaakinen A. Identification of five lymphocyte activating determinants in man. Tissue Antigens. 1975 Sep;6(3):147–160. doi: 10.1111/j.1399-0039.1975.tb00628.x. [DOI] [PubMed] [Google Scholar]
  29. Twomey J. J., Sharkey O. An adaptation of the mixed leukocyte culture test for use in evaluating lymphocyte and macrophage function. J Immunol. 1972 Apr;108(4):984–990. [PubMed] [Google Scholar]
  30. Twomey J. J., Sharkey O., Jr, Brown J. A., Laughter A. H., Jordan P. H., Jr Cellular requirements for the mitotic response in allogeneic mixed leukocyte cultures. J Immunol. 1970 Apr;104(4):845–853. [PubMed] [Google Scholar]
  31. Twomey P. L., Catalona W. J., Chretien P. B. Proceedings: Cellular immunity in cured cancer patients. Cancer. 1974 Feb;33(2):435–440. doi: 10.1002/1097-0142(197402)33:2<435::aid-cncr2820330219>3.0.co;2-a. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES